336 related articles for article (PubMed ID: 8127373)
1. Crystal structure of catechol O-methyltransferase.
Vidgren J; Svensson LA; Liljas A
Nature; 1994 Mar; 368(6469):354-8. PubMed ID: 8127373
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of the apo and holo form of rat catechol-O-methyltransferase.
Tsuji E; Okazaki K; Isaji M; Takeda K
J Struct Biol; 2009 Mar; 165(3):133-9. PubMed ID: 19111934
[TBL] [Abstract][Full Text] [Related]
3. Universal catalytic domain structure of AdoMet-dependent methyltransferases.
Schluckebier G; O'Gara M; Saenger W; Cheng X
J Mol Biol; 1995 Mar; 247(1):16-20. PubMed ID: 7897657
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases.
Bai HW; Shim JY; Yu J; Zhu BT
Chem Res Toxicol; 2007 Oct; 20(10):1409-25. PubMed ID: 17880176
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors.
Ellermann M; Lerner C; Burgy G; Ehler A; Bissantz C; Jakob-Roetne R; Paulini R; Allemann O; Tissot H; Grünstein D; Stihle M; Diederich F; Rudolph MG
Acta Crystallogr D Biol Crystallogr; 2012 Mar; 68(Pt 3):253-60. PubMed ID: 22349227
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of human 108V and 108M catechol O-methyltransferase.
Rutherford K; Le Trong I; Stenkamp RE; Parson WW
J Mol Biol; 2008 Jun; 380(1):120-30. PubMed ID: 18486144
[TBL] [Abstract][Full Text] [Related]
8. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of glycine N-methyltransferase from rat liver.
Fu Z; Hu Y; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
Biochemistry; 1996 Sep; 35(37):11985-93. PubMed ID: 8810903
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.
Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F
Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of rat catechol-O-methyltransferase complexed with coumarine-based inhibitor.
Tsuji E; Okazaki K; Takeda K
Biochem Biophys Res Commun; 2009 Jan; 378(3):494-7. PubMed ID: 19056347
[TBL] [Abstract][Full Text] [Related]
14. Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors.
Nissinen E; Männistö PT
Int Rev Neurobiol; 2010; 95():73-118. PubMed ID: 21095460
[TBL] [Abstract][Full Text] [Related]
15. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
Ovaska M; Yliniemelä A
J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the Escherichia coli 23S rRNA:m5C methyltransferase RlmI (YccW) reveals evolutionary links between RNA modification enzymes.
Sunita S; Tkaczuk KL; Purta E; Kasprzak JM; Douthwaite S; Bujnicki JM; Sivaraman J
J Mol Biol; 2008 Nov; 383(3):652-66. PubMed ID: 18789337
[TBL] [Abstract][Full Text] [Related]
17. Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values.
Reenilä I; Männistö PT
Med Hypotheses; 2001 Nov; 57(5):628-32. PubMed ID: 11735324
[TBL] [Abstract][Full Text] [Related]
18. CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease.
Zhu BT
Int J Mol Med; 2004 Mar; 13(3):343-53. PubMed ID: 14767563
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated and non-phosphorylated forms of catechol O-methyltransferase in rat liver, brain and other tissues.
Øverbye A; Seglen PO
Biochem J; 2009 Jan; 417(2):535-45. PubMed ID: 18831714
[TBL] [Abstract][Full Text] [Related]
20. Detoxication of structurally diverse polycyclic aromatic hydrocarbon (PAH) o-quinones by human recombinant catechol-O-methyltransferase (COMT) via O-methylation of PAH catechols.
Zhang L; Jin Y; Chen M; Huang M; Harvey RG; Blair IA; Penning TM
J Biol Chem; 2011 Jul; 286(29):25644-54. PubMed ID: 21622560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
